Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Himu Lukka

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
The Canadian Journal of Urology|July 18, 2002
Prostate cancer: risk categories and role of hormones and radiotherapyHimu Lukka
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 16, 2009
In favour of bladder preservation using combined modality treatmentHimu Lukka
Lancet (London, England)|June 23, 2019
The evolution of fractionated prostate cancer radiotherapyCharles Catton, Himu Lukka
The Journal of Urology|May 6, 2004
Baseline staging of newly diagnosed prostate cancer: a summary of the literatureSadeq Abuzallouf, Ian Dayes, Himu Lukka
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2018
Reply to J. David et alJarad Martin, Himu Lukka, Charles Catton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2018
Prostate Cancer Radiotherapy: An Evolving ParadigmCharles N Catton, Himu Lukka, Jarad Martin
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 6, 2019
Canadian Urological Association Best Practice Report: Diagnosis and management of radiation-induced hemorrhagic cystitisGeorge Goucher, Fred Saad, Himu Lukka, et al.
The Canadian Journal of Urology|September 6, 2006
The use of bisphosphonates in men with hormone-refractory prostate cancer: a systematic review of randomized trialsScott Berry, Tricia Waldron, Eric Winquist, et al.
Clinical Genitourinary Cancer|November 6, 2021
The Journey of Radiotherapy Dose Escalation in High Risk Prostate Cancer; Conventional Dose Escalation to Stereotactic Body Radiotherapy (SBRT) Boost TreatmentsAruz Mesci, Naghmeh Isfahanian, Ian Dayes, et al.
The Canadian Journal of Urology|March 7, 2006
GU radiation oncologists consensus on bone loss from androgen deprivationGraeme G Duncan, Tom Corbett, Himu Lukka, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
The Canadian Journal of Urology|July 18, 2002
Prostate cancer: risk categories and role of hormones and radiotherapyHimu Lukka
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 16, 2009
In favour of bladder preservation using combined modality treatmentHimu Lukka
Lancet (London, England)|June 23, 2019
The evolution of fractionated prostate cancer radiotherapyCharles Catton, Himu Lukka
The Journal of Urology|May 6, 2004
Baseline staging of newly diagnosed prostate cancer: a summary of the literatureSadeq Abuzallouf, Ian Dayes, Himu Lukka
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2018
Reply to J. David et alJarad Martin, Himu Lukka, Charles Catton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2018
Prostate Cancer Radiotherapy: An Evolving ParadigmCharles N Catton, Himu Lukka, Jarad Martin
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 6, 2019
Canadian Urological Association Best Practice Report: Diagnosis and management of radiation-induced hemorrhagic cystitisGeorge Goucher, Fred Saad, Himu Lukka, et al.
The Canadian Journal of Urology|September 6, 2006
The use of bisphosphonates in men with hormone-refractory prostate cancer: a systematic review of randomized trialsScott Berry, Tricia Waldron, Eric Winquist, et al.
Clinical Genitourinary Cancer|November 6, 2021
The Journey of Radiotherapy Dose Escalation in High Risk Prostate Cancer; Conventional Dose Escalation to Stereotactic Body Radiotherapy (SBRT) Boost TreatmentsAruz Mesci, Naghmeh Isfahanian, Ian Dayes, et al.
The Canadian Journal of Urology|March 7, 2006
GU radiation oncologists consensus on bone loss from androgen deprivationGraeme G Duncan, Tom Corbett, Himu Lukka, et al.
Pageof 5